Packages
Ready utility packages for implementation, licensing, integration and QC-focused commercial discussion.
Commercial utility suites
ArticlesRPH Tc-99m Renal Radiopharmaceutical and Imaging QC Suite
1616 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.
Radiopharmaceutical Diagnostics and Therapy QC Suite
3636 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.
RPH Tc-99m MAA Lung Perfusion and Radioembolization Planning QC Suite
13Quality control of Tc-99m MAA, particle size and count, suspension stability, lung perfusion studies, lung-shunt estimation, pre-therapy dosimetry and concordance with Y-90 distribution.
RPH Tc-99m Hepatobiliary and HIDA QC Suite
6Quality control of HIDA, mebrofenin and disofenin, hepatic extraction and gallbladder ejection calculations, and hepatobiliary transit review.
RPH Labelled Leukocyte Preparation and Release QC Suite
10Tc-99m HMPAO leukocyte labelling, labelling efficiency, cell viability and recovery, free activity, process time and temperature, and pre-reinjection release.
RPH Tc-99m Pertechnetate Functional Imaging QC Suite
5Sodium pertechnetate Tc-99m quality control and thyroid, salivary-gland, Meckel diverticulum and ectopic gastric-mucosa imaging workflows.
RPH Cr-51 Labelled Red Blood Cells QC Suite
6Red-cell mass and blood-volume calculations, Cr-51 labelling efficiency, elution correction, recovery-curve analysis and sample-timing control.
RPH Gastrointestinal Nuclear Medicine QC Suite
6Gastric-emptying and GI-transit review, labelled-RBC gastrointestinal bleeding scintigraphy and Tc-99m colloid liver/spleen studies.
RPH Pulmonary Ventilation and Perfusion QC Suite
10Tc-99m DTPA aerosol and Technegas control, aerosol-deposition review, V/Q mismatch evaluation and V/Q acquisition completeness.
RPH Lymphoscintigraphy and Sentinel Node QC Suite
6Tc-99m nanocolloid and tilmanocept control, injection review, acquisition QC, node-detection threshold and shine-through assessment.
RPH Labelled Blood Cells QC Suite
12In-111 and Tc-99m platelet labelling, cell recovery, autologous-cell release and cell-viability control.
RPH Infection and Inflammation Imaging QC Suite
10Ga-67 citrate, Tc-99m sulesomab and Tc-99m besilesomab control, plus antigranulocyte imaging acquisition review.
RPH use case: Tc-99m renal and nephrourology
17Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.
RPH use case: Tc-99m MAA, V/Q and radioembolization
18Macroaggregated albumin: particle size and count, radiochemical purity, resuspension, lung perfusion, lung shunt and pre-therapy Y-90 planning.
RPH use case: HIDA, hepatobiliary and GI nuclear medicine
20Hepatobiliary tracers, pertechnetate for Meckel/gastric mucosa, gastric emptying, GI transit, RBC bleeding and liver/spleen sulfur colloid.
RPH use case: labelled cells and blood-pool workflows
24Leukocytes, red blood cells, platelets and autologous cell workflows: labeling efficiency, viability, free activity, recovery and release before reinjection.
RPH use case: Tc-99m pertechnetate and functional imaging
3Pertechnetate as a standalone radiopharmaceutical and starting material: thyroid uptake, salivary glands, Meckel scan, gastric mucosa and generator/eluate control.
RPH use case: cardiac, bone and classic SPECT radiopharmaceuticals
7Sestamibi, tetrofosmin, MDP, pyrophosphate, thallium and related quality checks for cardiology, bone imaging and classic SPECT protocols.
RPH use case: PET/SPECT oncology diagnostics and receptor imaging
26F-18, Ga-68, Cu-64, Zr-89, In-111 and other diagnostic tracers: synthesis, purity, receptor targeting, immuno-PET and generator-based workflows.
RPH use case: radionuclide therapy and theranostics
67Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.
RPH use case: generators, isotope purity and starting radionuclides
39Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.
RPH use case: xenon, ventilation and medical gases
29Xe-129, Xe-133, Xe-127, hyperpolarization, SEOP, T1, mixing, scavenging, transport, recovery and ventilation imaging.
RPH use case: PET scanner state, gamma camera and radiation physics
29The linked medical-device/radiation-physics layer: PET detector QC, normalization, AC map, cross-calibration, TOF, gamma-camera uniformity, source strength and staff dose.
RPH isotope family: Tc-99m
87Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.
RPH isotope family: short-lived PET isotopes
17F-18, C-11, N-13, O-15 and related PET production, release and imaging workflows.
RPH isotope family: Ga/Ge
18Ga-67, Ga-68 and Ge-68: generator, radiolabelling, PET/SPECT and purity workflows.
RPH isotope family: radioiodine
16I-123, I-124, I-125 and I-131 for diagnostics, therapy, labelling and purity control.
RPH isotope family: beta-emitting therapy
35Lu-177, Y-90, Ho-166, Re-188, Sm-153, Sr-89, P-32, Cu-67 and Tb-161.
RPH isotope family: alpha-emitting therapy
12Ac-225, Ra-223, At-211, Bi-213 and Th-227: targeted alpha therapy and daughter/recoil control.
RPH isotope family: long-lived PET / immuno-PET
15Cu-64, Zr-89, I-124, Mn-52 and Y-86 for antibodies, slow kinetics and extended imaging.
RPH isotope family: labelled cells and blood
16In-111 and Cr-51 for labelled cells, blood volume, RBC/WBC and survival workflows.
RPH isotope family: cardiac perfusion and generator tracers
6Rb-82/Sr-82, N-13 and Tl-201 for myocardial perfusion and generator-supported workflows.
RPH isotope family: xenon and gas tracers
29Xe-127, Xe-129 and Xe-133 for ventilation, hyperpolarized imaging, gas QC and safety.
RPH organ/system: renal and urinary
59Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.
RPH organ/system: pulmonary and ventilation
67Lung perfusion, MAA, V/Q, aerosol, xenon ventilation, shunt and pulmonary dosimetry.
RPH organ/system: hepatobiliary and GI
130HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
RPH organ/system: cardiovascular
20Myocardial perfusion, cardiac PET/SPECT, ventricular function, blood-pool and perfusion tracers.
RPH organ/system: brain and CNS
45Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.
RPH organ/system: endocrine, thyroid and NET
70Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.
RPH organ/system: bone and musculoskeletal
82Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.
RPH organ/system: blood, cells and marrow
28WBC/RBC/platelet labelling, blood volume, survival, blood-pool and cellular release workflows.
RPH organ/system: lymphatic, infection and inflammation
26Sentinel node, lymphoscintigraphy, nanocolloid, labelled leukocytes, granulocyte and inflammatory imaging.
RPH organ/system: oncology and theranostics
136Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
RPH workflow: synthesis, labelling and kit reconstitution
96Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
RPH workflow: product release QC
199Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
RPH workflow: generators and isotope purity
122Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.
RPH workflow: dosimetry and therapy planning
59Activity planning, absorbed dose, organ dose, lung shunt, preplanning and therapy verification.
RPH workflow: imaging QC and quantitative interpretation
167Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
RPH workflow: stability, storage, decay and waste
138Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
RPH workflow: instruments, devices and radiation safety
67PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.